Loading patent…
AssigneeDecipher Biosciences, Inc.
InventorsElai Davicioni, Nicholas Erho, Hussam Al-Deen Ashab, Mohammed Alshalalfa
Estimating the term…
The present invention relates to methods, systems and kits for the diagnosis, prognosis and the determination of cancer progression of prostate cancer in a subject. The invention also provides clinically useful genomic classifiers for predicting prostate cancer metastasis and identifying tumor aggressiveness. The methods, systems and kits can provide expression-based analysis of biomarkers for purposes of predicting metastatic disease and lethal prostate cancer in a subject. Further disclosed herein, in certain instances, are probe sets for use in predicting prostate cancer metastasis in a subject. Classifiers for predicting prostate cancer metastasis are provided. Methods of treating cancer based on tumor aggressiveness are also provided. The methods and classifiers of the present invention are also useful for predicting early prostate cancer metastasis.
A method comprising:
11-19. (canceled)
A kit for predicting cancer aggressiveness or risk of metastasis, the kit comprising agents for assaying an expression level of a plurality of genes, wherein said plurality of genes comprises one or more genes selected from Table 1 or SEQ ID NOs:
A system for analyzing a cancer, comprising:
A probe set for prognosing or diagnosing cancer in a subject, the probe set comprising a plurality of probes for detecting a plurality of target nucleic acids, wherein the plurality of target nucleic acids comprises one or more gene sequences, or complements thereof, of genes selected from Table 1.
Dependencies are inferred from the claim text.